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the eccrine glands responsible for sweat secretion resulting
in subsequent vasoconstriction and cooling of skin.3 In a
study conducted by Lin and Fang,4 abnormal sympathetic
skin responses have been shown in patients with hyper-
hidrosis and may be due to regulatory dysfunction, as well
as sympathetic hyperactivity. It has also been postulated
that the center in the hypothalamus that controls sweating
of the palms and soles is regulated by cortical input and
thus differs from the other hypothalamic sweat centers.5
Further evidence has also revealed that on challenge with
hyperventilation, patients with hyperhidrosis show abnor-
mal wave bursts on electroencephalography and possible
hyperperfusion of the frontal cortex.6
Although considered a benign condition, the psycho-
logic, social, and professional burden to those afflicted with
hyperhidrosis can be disabling. There are numerous conser-
vative therapies used in the treatment of hyperhidrosis,
including antiperspirants, tap water iontophoresis, botulin
toxin A, anticholinergic drugs, and psychotherapy7-13; how-
ever, most patients seldomly find permanent relief from
conservative management because the palliative effects are
usually transient and successful only for mild cases.
Thoracoscopic sympathectomy is now primarily performed
for treatment of palmar hyperhidrosis by resecting the sym-
pathetic chain and ganglia in the upper thoracic region (T2-
T3) to increase blood flow through the cutaneous
Primary palmar hyperhidrosis is a condition marked by
excessive perspiration beyond physiological need and is
reported to have an incidence of 0.6% to 1.0% in the
Western population.1,2 The excessive sweating often
begins in childhood and is primarily of the upper extrem-
ities but may involve the plantar surfaces and axillae as
well. The degree of sweating is variable, ranging in sever-
ity from moderate moisture to severe dripping, and it can
be aggravated during periods of stress and anxiety.
Although the pathophysiology of the condition is uncer-
tain, it is believed that the overactivity of the sympathetic
cholinergic fibers passing through the upper dorsal sym-
pathetic ganglia at T2-T3 causes abnormal innervation of
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Background: Primary palmar hyperhidrosis is a condition marked by excessive perspiration and is reported to have an
incidence of 1% in the Western population. It is a potentially disabling disorder that interferes with social, psycholog-
ical, and professional activities. Over the past several years, several investigators have reported a positive family history
in their patients treated for hyperhidrosis. To date, the cause is unknown; furthermore, epidemiologic data are scarce
and inadequate.
Methods: To characterize the genetic contribution to hyperhidrosis, we conducted a prospective study of 58 consecutive
patients with palmar, plantar, or axillary hyperhidrosis treated with thoracoscopic sympathectomy from September
1993 to July 1999. Forty-nine of the 58 probands volunteered family history data for these analyses (84% response
rate). A standardized questionnaire was administered during the postoperative visit or by phone interview, and a
detailed family history was obtained. The same questionnaire was also administered to a set of 20 control patients. The
familial aggregation of hyperhidrosis has been quantified by estimating the recurrence risks to the offspring, parents,
siblings, aunts, uncles, and cousins of 49 probands and 20 controls. We estimated the penetrance by use of a genetic
analysis program.
Results: Thirty-two of 49 (65%) reported a positive family history in our hyperhidrosis group, and 0% reported a pos-
itive family history in our control group. A recurrence risk of 0.28 in the offspring of probands compared with fre-
quency of 0.01 in the general population provides strong evidence for vertical transmission of this disorder in pedigrees
and is further supported by the 0.14 risk to the parents of the probands. The results indicate that the disease allele is
present in about 5% of the population and that one or two copies of the allele will result in hyperhidrosis 25% of the
time, whereas the normal allele will result in hyperhidrosis less than 1% of the time.
Conclusions: We conclude that primary palmar hyperhidrosis is a hereditary disorder, with variable penetrance and no
proof of sex-linked transmission. However, this does not exclude other possible causes, and we anticipate that genetic
confirmation of this disorder may lead to earlier diagnoses and advances in medical and psychosocial interventions.
(J Vasc Surg 2002;35:382-6.)
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arteriovenous fistula and decrease sweating in the ipsilateral
hand. Application of this technique has been fueled by
impressive technical and patient satisfaction rates, with suc-
cess rates ranging from 71% to 100%.14 Possible short-term
complications include pneumothorax, hemothorax, subcu-
taneous emphysema, pleural effusion, and segmental atelec-
tasis. Incomplete reinflation of the collapsed apical lobe will
result in postoperative complications from atelectasis and
pneumothorax. Rare complications include false aneurysm
of the intercostal artery and inferior brachial plexus injury.
Long-term complications include compensatory sweating in
the trunk or lower extremities, intercostal neuralgia, and
Horner’s syndrome. Compensatory hyperhidrosis is the
most common and unpredictable side effect and is reported
in 0% to 74.5% of cases, with anecdotal evidence suggesting
that the sweating subsides over time.14
To date, the cause of hyperhidrosis is unknown; fur-
thermore, epidemiologic data are scarce and inadequate.
Over the past several years, different investigators have
reported positive family histories in their patients treated for
hyperhidrosis, ranging from 5% to 50%; however, no further
empirical data have been offered.15-20 To characterize the
genetic contribution to hyperhidrosis, we conducted a
prospective study of 58 consecutive patients with palmar,
plantar, and axillary hyperhidrosis treated with thoraco-
scopic sympathectomy from September 1993 to July 1999.
METHODS
Study population. The University of California at
Los Angeles (UCLA) Center for Health Science Study on
hyperhidrosis is a prospective study consisting of 58
patients who received treatment at the UCLA Medical
Center from September 1993 to July 1999. Patient char-
acteristics are shown in Tables I and II. Four additional
patients were evaluated for hyperhidrosis but were not
included in this study because these patients did not receive
treatment at our institution, and follow-up data were unat-
tainable after their initial visit. Indication for surgery was
severe and debilitating primary palmar hyperhidrosis with
failed conservative management with psychosocial seque-
lae. The population consisted of 35 white or Middle
Eastern persons, 18 of Asian/Pacific Island origin, 4
Hispanics, and 1 black person (36 males and 22 females),
with a mean age at operation of 31.7 years (range 16 to 66
years). All 58 patients were ruled out for hypermetabolic
states by history, thyroid function test results, and physical
examination and were found to be otherwise healthy with
no other significant medical condition. The senior author
personally observed profuse, nonphysiological sweating in
each patient; in each case, it was quite obvious, and starch
iodine and other tests for sweat chloride were not per-
formed. However, the first author did not grade the degree
of sweating in each patient, and thus no association
between this and family history was made. Various tools
have been devised to support the diagnosis of palmar
hyperhidrosis, including metal corrosion tests and starch-
iodine tests; however, such quantitative assessments are
now considered obsolete as the excessive perspiration is
visually obvious and an accurate diagnosis can be made by
careful history and physical examination.2 Furthermore,
reported symptoms were unanimously socially or profes-
sionally disabling, with most patients undergoing extensive
failed medical therapy before surgical intervention.
Table I. Patient characteristics
Total patients 58
Average age 31.7 y (range 16-66 y)
Males 62%
Hyperhidrosis type
Palmar only 45% (26)
Palmar and plantar 50% (29)
Palmar and axillae 3.4% (2)
Palmar, plantar, and axillae 1.7% (1)
Questionnaire response rate 84%
Positive family history 65%
Table II. Ethnicity of patients with hyperhidrosis
White 53% (31)
Asian/Pacific Islander 31% (18)
Hispanic 6.9% (4)
Middle Eastern 6.9% (4)
Black 1.7% (1)
Pedigree shows strong degree of familiarity.
A
B
These 58 patients underwent minimally invasive tho-
racoscopic sympathectomy by use of the techniques previ-
ously described by Ahn et al.21 Of those patients treated at
the UCLA Medical Center to date, the success rate has
been 100% with no recurrence of symptoms. All patients
had an excellent immediate sympatholytic response, fur-
ther confirming their preoperative diagnosis.
We also obtained 20 control subjects who were seen
by the senior author at the UCLA Medical Center for
treatment of thoracic outlet syndrome. The control
patients were chosen randomly from a group of patients
with thoracic outlet syndrome and with demographics
similar to our study population (87% response rate, 30%
males, mean age 35 years, range 16 to 59 years); they were
then administered the same questionnaire as our affected
group. The controls consisted of 16 white persons, 2
Asians, and 2 individuals of Middle-Eastern descent.
Patients in both the hyperhidrosis and control groups
were otherwise healthy.
Measurements. Forty-nine of the 58 probands vol-
unteered family history data for these analyses (84%
response rate). Each of the 49 families in the study was
ascertained through a proband with clinically validated
hyperhidrosis. A standardized questionnaire was admin-
istered during the postoperative visit or by phone inter-
view, and a detailed family history was obtained. The
proband was queried with regard to the structure of his
or her pedigree, and first- and second-degree relatives of
the proband were identified. Patients were asked age,
sex, ethnicity, medical history, marital status, number of
children, number of aunts and uncles, number of sib-
lings, and the number of siblings’ children. The proband
was then asked to individually identify the affected and
nonaffected family members. Forty-nine pedigrees with
32 offspring, 98 parents, 148 siblings, 224 aunts and
uncles, and 93 nieces and nephews have been analyzed.
Hyperhidrosis status was ascertained in the relatives of
the proband by the proband, who were all personally
knowledgeable and familiar with the diagnosis of hyper-
hidrosis. If the proband was uncertain of the hyper-
hidrosis state of specific family members, these relatives
were considered unaffected.
Method of analysis. The familial aggregation of
hyperhidrosis has been quantified by estimating the recur-
rence risks to the offspring, parents, siblings, aunts, uncles,
and cousins of 49 probands. The estimates have been
made without regard to ethnic group or sex, because we
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found no evidence of ethnic variation in our series.
Because most of the pedigrees with multiple affected
members show transmission from generation to genera-
tion, we have postulated that the susceptibility for devel-
opment of hyperhidrosis may result from the effects of a
major gene. However, a recurrence risk of 50% in the first-
degree relatives, which is consistent with dominant inher-
itance, has not been observed, indicating that this major
gene may not be fully penetrant or others may have been
affected but not identified. We have estimated the pene-
trance, or the likelihood for development of hyperhidrosis,
given the postulated predisposing major gene, by use of
the MENDEL package of genetic analysis programs.22
The disease allele frequency and penetrance of the
homozygotic and heterozygotic disease genotypes and
normal genotype were estimated by maximizing the likeli-
hood of the observed pattern of inheritance in the pedi-
grees, and the standard errors of the estimates have been
calculated numerically.
RESULTS
Thirty-two of 49 patients (65%) reported a positive
family history. Several of the 17 patients with no known
family history had a limited recall of the structure of their
extended family, one patient was adopted, and another
was born to a mother who herself was adopted. There was
no reported consanguinity.
The Figure shows pedigrees that illustrate a particularly
strong degree of familial aggregation. Included in the
Figure are affected individuals in generations beyond those
used in the analyses. The recurrence risks for each of the
classes of relatives studied in these analyses are reported in
Table III. These data provide ample evidence that primary
hyperhidrosis is familial. A recurrence risk of 0.28 in the off-
spring of probands compared with a frequency of 0.01 in
the general population provides strong evidence for vertical
transmission of this disorder in pedigrees and is further sup-
ported by the 0.14 risk to the parents of the probands. This
estimate is attributed to the fact that one half of the parents
of the probands will probably not carry the major gene con-
tributing to hyperhidrosis so that the risk to parents in the
adjusted sample is 0.28, the same risk as that of the off-
spring. The risk to siblings is 0.07, which is quite low com-
pared with the other first-degree relatives. The relatively
low risk to siblings may be explained if the proband has only
limited recall of his/her family or is unaware of the hyper-
hidrosis status of his or her siblings. Aunts, uncles, nieces,
Table III. Recurrence risks for each class of relatives in 49 hyperhidrosis pedigrees
Class No. relatives No. of affected relatives Empiric risk
Offspring 32 9 0.28
Parents 98 14 0.14
Siblings 148 10 0.07
Aunt/Uncle 224 9 0.04
Niece/Nephew 93 5 0.05
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and nephews, all having the same degree of relationship to
the proband, have a similar recurrence risk (0.04 vs 0.05).
These individuals share 0.25 of their genes with the
proband, so a penetrance of 0.25 estimated by the pedigree
analysis should result in an empiric risk of 0.06, which is
fairly consistent with the estimated risk.
Our estimated penetrance of 0.25 for hyperhidrosis
can be compared with those of known familial disorders
such as breast cancer (BRCA1 gene), schizophrenia, and
idiopathic torsion dystonia (DYT1 gene), which have been
estimated at 0.7 (by age 70), 0.31 to 0.51 (dominant
inheritance), and 0.46, respectively.23-25 Although the
penetrance value in our study population is less than with
these familial disorders, it is suggestive of a familial aggre-
gation with a possible multigenic mechanism.
Among the 20 control families ascertained for hyper-
hidrosis, there were 40 parents, 45 siblings, 18 offspring,
and 47 nieces and nephews. Each control proband was
questioned about hyperhidrosis in similar fashion to those
families ascertained for the disorder. No one reported a
relative with hyperhidrosis, indicating that the risk to rela-
tives in the general population is low compared with that
in the families with hyperhidrosis. These data indicate that
the frequency of hyperhidrosis of first degree relatives in
the general population is at most 3% with 95% confidence,
and may even be considerably lower. The fact that no one
in our control group had this condition may be attributed
to sampling variability or underreporting. The risk in our
sample of first degree relatives of hyperhidrosis patients is
clearly much higher at 12%.
Table IV delineates the penetrance estimates of the
disease gene for the possible genotypes. The result of this
analysis indicates that the disease allele is present in about
5% of the population and that one or two copies of the
allele will result in hyperhidrosis 25% of the time, whereas
the normal allele will result in hyperhidrosis less than 1%
of the time.
DISCUSSION
In McKusick’s Mendelian Inheritance in Man,26 pal-
mar and plantar hyperhidrosis (144110) is identified as a
“clear familial disorder” with implications of an autosomal
dominant origin. Additional studies have also suggested a
genetic cause.15-20 As far back as 1967, Mailander27
reported a case of hereditary gustatory hyperhidrosis in a
three-generation pedigree with five affected individuals;
furthermore, the author reported an instance of a skipped
generation with no proof of sex-linked transmission.
However, this conclusion was drawn solely on the basis of
anecdotal evidence; the absence of sound empirical evi-
dence or data has made such suggestions inconclusive.
In further support of a possible genetic cause, some
investigators have estimated a higher incidence of hyper-
hidrosis among specific populations, especially among
Asians. McKusick26 claims there may be an unusually high
frequency among the Chinese, and Cloward28 reported a
greater development of hyperhidrosis in Japanese-American
persons living in Hawaii compared with non-Japanese
Hawaiian residents. There is no evidence to suggest there is
a higher prevalence among men versus women.
Several other diseases and syndromes have been asso-
ciated with hyperhidrosis. Noppen and Vincken20
described two patients with Turner’s syndrome who also
were diagnosed with palmar hyperhidrosis. Although they
acknowledge the possibility that the two patients affected
(of the 150 patients with Turner syndrome studied) may
be coincidental, the apparent rarity of both disorders sug-
gests that this association may be more common than pre-
viously reported. Several genetic disorders are also
associated with the manifestation of hyperhidrosis includ-
ing pachydermoperiostosis, pachyonychia congenita,
inflammatory familial palmoplantar keratoderma, ectoder-
mal dysplasia, Book syndrome, Meleda disease, and nail
patella syndrome.29-34 Most recently, Stromme et al35 in
their description of the localization of the cross-linked
mental retardation disease gene Xp11.4-Xp22.11 found
that 12 of the 13 patients examined had a history of hyper-
hidrosis. A pedigree analysis suggested that the disorder
segregated independently as an autosomal dominant trait
and was not inherited as a cross-linked trait.
Hyperhidrotic disorders are associated with previous
spinal cord injuries such as posttraumatic syringomyelia,
autonomic dysreflexia, and peripheral neuropathies,
including familial dysautonoma.5,36 Systemic illness, brain
lesions, or intrathoracic neoplasms are also known to cause
generalized hyperhidrosis.5 All 58 patients in our study
were otherwise healthy and had idiopathic primary hyper-
hidrosis not caused by another disease or pathologic state.
If hyperhidrosis is truly a condition caused by hyperac-
tivity of the sympathetic nervous system, the peripheral cate-
cholamine levels in patients with hyperhidrosis should exceed
normal levels. In another recent study, Noppen et al37 mea-
sured plasma catecholamine level in patients with primary
hyperhidrosis before and after thoracoscopic sympathectomy
and found the levels of norepinephrine to be markedly
reduced, whereas that of epinephrine were unchanged. The
authors concluded that primary hyperhidrosis is not related
to general sympathetic overactivity but results from a local-
ized overactivity of the upper dorsal ganglia.
This preliminary study has several limitations. The
hyperhidrotic status of the family members was limited to
the recall of our proband. We were unable to determine a
definitive clinical diagnosis of the family members reported
positive for hyperhidrosis. We did not contact the relatives
of the proband given that many of them were deceased,
Table IV. Estimated allele frequency and genotype
penetrance of major susceptible gene
Genotype Estimate Standard error
Dx allele frequency 0.048 0.036
Dx/dx penetrance 0.2543 0.59
Dx/nl penetrance 0.2540 0.083
Nl/nl penetrance 0.0049 0.006
Dx, Diseased; nl, normal.
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lived outside of the United States, or had been out of con-
tact with their relatives. Because of the embarrassing nature
of this condition, affected individuals have historically been
reluctant to discuss this condition with others and often
deny having any abnormal sweating. As a consequence, our
data may have been affected by recall bias and nonresponse
bias by those who did not answer our questionnaire, and
the true penetrance of the disorder might be underesti-
mated. Consideration must also be given to the potential
for ascertainment bias, with subjects admitted for surgical
intervention of hyperhidrosis potentially more likely to
provide information of a positive family history when
queried. Nonetheless, our data should reflect an accurate
prevalence of familial hyperhidrosis given a response rate of
84% and a prevalence of hyperhidrosis of 0% in our control
population. Many affected individuals are hesitant to seek
treatment; therefore the prevalence of 1% reported in the
current literature may be a gross underestimation. Our
observed penetrance of 25% and allele frequency of 5%
suggest a higher true prevalence of the condition.
With increasing awareness among physicians and
patients of treatment options, we expect the identification
of individuals with hyperhidrosis to increase substantially
and future studies to become more reliable. We believe the
data help support the theory that hyperhidrosis is indeed
a real clinical disorder with a physiological basis, not a dis-
order of behavioral origin. Surgical treatment has provided
long-lasting effects in all our patients, further sustaining a
biologic basis of the disorder. We anticipate that this study
will help remove some of the stigma associated with pri-
mary hyperhidrosis, enable patients and physicians to
accept the disorder as a medically validated condition, and
encourage patients to seek treatment.
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